oxazoles has been researched along with harmaline in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (87.50) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (12.50) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Costa, E; Guidotti, A; Naik, SR | 1 |
Biggio, G; Brodie, BB; Costa, E; Guidotti, A | 1 |
Bizière, K; Kan, JP; Mouget-Goniot, C; Steinberg, R; Worms, P | 1 |
Hirate, K; Shinozaki, H | 1 |
Fuller, RW; Hemrick-Luecke, SK | 1 |
Fuller, RW; Hemrick-Luecke, SK; Wong, CJ | 1 |
Kan, JP; Strolin Benedetti, M | 1 |
Dresse, A; Gerardy, J | 1 |
8 other study(ies) available for oxazoles and harmaline
Article | Year |
---|---|
Central GABA receptor agonists: comparison of muscimol and baclofen.
Topics: Aminobutyrates; Animals; Anticonvulsants; Baclofen; Cerebellum; Cyclic GMP; Diazepam; gamma-Aminobutyric Acid; Harmaline; Isoniazid; Male; Motor Activity; Muscle Tonus; Mycotoxins; Oxazoles; Phenobarbital; Quaternary Ammonium Compounds; Rats; Receptors, Drug; Strychnine; Substance P | 1976 |
Mechanisms by which diazepam, muscimol, and other drugs change the content of cGMP in cerebellar cortex.
Topics: Alkaloids; Animals; Cerebellar Cortex; Cyclic GMP; Diazepam; Haloperidol; Harmaline; Isoxazoles; Male; Morphine; Oxazoles; Purkinje Cells; Pyridines; Rats | 1977 |
SR 95191, a selective inhibitor of type A monoamine oxidase with dopaminergic properties. II. Biochemical characterization of monoamine oxidase inhibition.
Topics: Animals; Benzamides; Biogenic Amines; Brain; Clorgyline; Dopamine; Duodenum; Harmaline; Isoenzymes; Liver; Moclobemide; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Oxazoles; Oxazolidinones; Pyridazines; Rats; Selegiline; Synaptosomes | 1987 |
Depression of drug-induced tremor by a new isoxazol derivative in mice.
Topics: Animals; Diazepam; Dose-Response Relationship, Drug; Harmaline; Isoxazoles; Male; Mice; Mice, Inbred ICR; Motor Activity; Oxazoles; Tremor; Tremorine | 1986 |
Influence of selective, reversible inhibitors of monoamine oxidase on the prolonged depletion of striatal dopamine by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Alkaloids; Animals; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Harmaline; Homovanillic Acid; Male; Mice; Monoamine Oxidase Inhibitors; Oxazoles; Oxazolidinones; Oxidation-Reduction; Pyridines | 1985 |
MD 240928 and harmaline: opposite selectivity in antagonism of the inactivation of types A and B monoamine oxidase by pargyline in mice.
Topics: Alkaloids; Animals; Brain; Harmaline; Isoenzymes; Liver; Male; Mice; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Myocardium; Oxazoles; Oxazolidinones; Pargyline; Time Factors | 1986 |
Characteristics of the inhibition of rat brain monoamine oxidase in vitro by MD780515.
Topics: Animals; Brain; Harmaline; In Vitro Techniques; Male; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Oxazoles; Oxazolidinones; Phenethylamines; Rats; Serotonin | 1981 |
Comparative effects of dehydropirlindole and other compounds on rat brain monoamine oxidase type A.
Topics: Animals; Brain; Carbazoles; Clorgyline; Harmaline; Kinetics; Male; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Oxazoles; Rats; Rats, Wistar | 2002 |